These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 2533187

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E.
    Rev Prat; 1994 Jan 01; 44(1):69-74. PubMed ID: 8178062
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D, Aharoni R, Klinger E, Kreitman R, Raymond E, Malley A, Shofti R, Sela M, Arnon R.
    Ann N Y Acad Sci; 2004 Dec 01; 1029():239-49. PubMed ID: 15681762
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis.
    Jameson BA, McDonnell JM, Marini JC, Korngold R.
    Nature; 1994 Apr 21; 368(6473):744-6. PubMed ID: 8152486
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y, Suárez-Luis I.
    Rev Neurol; 1994 Apr 21; 36(7):649-52. PubMed ID: 12666047
    [Abstract] [Full Text] [Related]

  • 14. Clinical experience with COP-1 in multiple sclerosis.
    Bornstein MB, Miller A, Slagle S, Weitzman M, Crystal H, Drexler E, Keilson M, Merriam A, Wassertheil-Smoller S, Spada V.
    Neurology; 1988 Jul 21; 38(7 Suppl 2):66-9. PubMed ID: 3290717
    [Abstract] [Full Text] [Related]

  • 15. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
    Tutaj M, Szczepanik M.
    J Autoimmun; 2007 Jun 21; 28(4):208-15. PubMed ID: 17442539
    [Abstract] [Full Text] [Related]

  • 16. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T.
    Minerva Med; 2008 Apr 21; 99(2):119-40. PubMed ID: 18431322
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA, Kamoun M, Ventura E, Rostami A.
    Exp Mol Pathol; 2000 Feb 21; 68(1):29-37. PubMed ID: 10640452
    [Abstract] [Full Text] [Related]

  • 18. Multiple sclerosis: trial of a synthetic polypeptide.
    Bornstein MB, Miller AI, Teitelbaum D, Arnon R, Sela M.
    Ann Neurol; 1982 Mar 21; 11(3):317-9. PubMed ID: 7092185
    [Abstract] [Full Text] [Related]

  • 19. Molecular and cellular determinants of neuroimmunologic inflammatory disease.
    Paterson PY.
    Fed Proc; 1982 Jul 21; 41(9):2569-76. PubMed ID: 6177557
    [Abstract] [Full Text] [Related]

  • 20. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
    Ramírez F, Mason D.
    Eur J Immunol; 2000 Mar 21; 30(3):747-58. PubMed ID: 10741389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.